What's new

Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that patent JP6336080B—covering the Smart-seq2 method, developed by Rickard Sandberg and exclusively licensed to TBUSA by the Ludwig Institute—has been awarded by the Japan Patent Office.

07/18/2018

Takara Bio is pleased to announce the launch of our newly redesigned website. Its expanded features include a revamped homepage, enhanced search, improved responsiveness, and expanded learning resources.

07/03/2018

Mountain View, CA—May 17, 2018—The Takara Bio Group, the leading provider of human stem cell differentiation services globally, has launched the Cellartis Directed Differentiation to Beta Cells Service for the delivery of high-quality, custom human induced pluripotent stem cell (hiPSC)-derived beta cells for diabetes research and metabolic disease modeling.

05/17/2018

Mountain View, CA—May 8, 2018—A recent study including single-cell transcriptome analysis has revealed an evolutionary model of chemoresistance in triple-negative breast cancer (TNBC) patients. This groundbreaking work, led by Professor Nicholas Navin (The University of Texas MD Anderson Cancer Center), was published in the May issue of Cell and utilized Takara Bio’s SMARTer ICELL8 single-cell automation platform.

05/08/2018

Featured information

In this webinar, Dr. Nathalie Bolduc (Takara Bio USA, Inc.) presents data from the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian, which generates Illumina-ready sequencing libraries from 250 pg–10 ng mammalian total RNA inputs of any quality, including FFPE samples.

Our start-to-finish editing and single-cell cloning kits make human iPS cell editing routine instead of frustrating. In this video protocol, we provide step-by-step instructions for generating edited human iPS cell lines using our complete system for electroporation-based delivery of RNP complexes and single-cell cloning. This high-efficiency workflow greatly improves single-cell survival post-seeding, thanks to the Cellartis DEF-CS culture system. In addition to our electroporation-based kit, we also offer an alternate kit that uses gesicles to deliver RNP complexes.